# POLYVINYL ACETATE

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid3051258
Categories: cleaning, industrial, pharma
Functions: Adhesion/cohesion promoter, Anti-static agent, Binder, Degradant/impurity, Emulsifier, Film former, Hair fixative, Stabilizing agent, Thickening agent, backing, main constituent, pre-glued dowels: pvac glue (component
Identifier: DTXSID3051258

> POLYVINYL ACETATE is used as adhesion/cohesion promoter / anti-static agent. EPA CPDat observed this chemical in 422 composition records across product categories including Construction and building materials, Furniture and furnishings, Other indirect contact consumer goods. Assessed from 13 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 422 composition records across product categories including Construction and building materials, Furniture and furnishings, Other indirect contact consumer goods.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 422 composition records across product categories including Construction and building materials, Furniture and furnishings, Other indirect contact consumer goods. EPA CPDat classifies this chemical for functional uses including Film former, Anti-static agent, Emulsifier.
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 122 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Potency: 92.9 mg/5ml
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Potency: 7 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE, EXTENDED RELEASE; Maximum daily exposure: 39 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 225 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Potency: 6.5 mg
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Potency: 8.07 mg
- US: inactive ingredient database — Route: TRANSDERMAL; Dosage form: SYSTEM; Potency: 16 mg
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as polymer.

_Assessed by Greenveil._